These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31302238)

  • 1. Glycine transporter inhibitors: A new avenue for managing neuropathic pain.
    Al-Khrasani M; Mohammadzadeh A; Balogh M; Király K; Barsi S; Hajnal B; Köles L; Zádori ZS; Harsing LG
    Brain Res Bull; 2019 Oct; 152():143-158. PubMed ID: 31302238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term application of glycine transporter inhibitors acts antineuropathic and modulates spinal N-methyl-D-aspartate receptor subunit NR-1 expression in rats.
    Barthel F; Urban A; Schlösser L; Eulenburg V; Werdehausen R; Brandenburger T; Aragon C; Bauer I; Hermanns H
    Anesthesiology; 2014 Jul; 121(1):160-9. PubMed ID: 24598217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
    Dohi T; Morita K; Kitayama T; Motoyama N; Morioka N
    Pharmacol Ther; 2009 Jul; 123(1):54-79. PubMed ID: 19393690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion--Possible implications for neuropathic pain.
    Schlösser L; Barthel F; Brandenburger T; Neumann E; Bauer I; Eulenburg V; Werdehausen R; Hermanns H
    Neurosci Lett; 2015 Jul; 600():213-9. PubMed ID: 26101830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
    Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T
    J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Glycine Re-Uptake: A Potential Approach for Treating Pain by Augmenting Glycine-Mediated Spinal Neurotransmission and Blunting Central Nociceptive Signaling.
    Cioffi CL
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34200954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord.
    Winters BL; Rawling T; Vandenberg RJ; Christie MJ; Bhola RF; Imlach WL
    Br J Pharmacol; 2018 Jun; 175(12):2337-2347. PubMed ID: 29500820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model.
    Mohammadzadeh A; Lakatos PP; Balogh M; Zádor F; Karádi DÁ; Zádori ZS; Király K; Galambos AR; Barsi S; Riba P; Benyhe S; Köles L; Tábi T; Szökő É; Harsing LG; Al-Khrasani M
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33804568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord.
    Bradaïa A; Schlichter R; Trouslard J
    J Physiol; 2004 Aug; 559(Pt 1):169-86. PubMed ID: 15235081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
    Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
    Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive effect of intracerebroventricular administration of glycine transporter-2 inhibitor ALX1393 in rat models of inflammatory and neuropathic pain.
    Takahashi Y; Hara K; Haranishi Y; Terada T; Obara G; Sata T
    Pharmacol Biochem Behav; 2015 Mar; 130():46-52. PubMed ID: 25579325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive N-methyl-D-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo.
    Whitehead KJ; Pearce SM; Walker G; Sundaram H; Hill D; Bowery NG
    Neuroscience; 2004; 126(2):381-90. PubMed ID: 15207356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
    Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
    Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from the knocked-out glycine transporters.
    Gomeza J; Armsen W; Betz H; Eulenburg V
    Handb Exp Pharmacol; 2006; (175):457-83. PubMed ID: 16722246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of glycine transporter (GlyT) 2, but not GlyT1, ameliorates dynamic and static mechanical allodynia in mice with herpetic or postherpetic pain.
    Nishikawa Y; Sasaki A; Kuraishi Y
    J Pharmacol Sci; 2010; 112(3):352-60. PubMed ID: 20173309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF contributes to the development of neuropathic pain by induction of spinal long-term potentiation via SHP2 associated GluN2B-containing NMDA receptors activation in rats with spinal nerve ligation.
    Ding X; Cai J; Li S; Liu XD; Wan Y; Xing GG
    Neurobiol Dis; 2015 Jan; 73():428-51. PubMed ID: 25447233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological evidence of increased glycine receptor-mediated phasic and tonic inhibition by blockade of glycine transporters in spinal superficial dorsal horn neurons of adult mice.
    Oyama M; Kuraoka S; Watanabe S; Iwai T; Tanabe M
    J Pharmacol Sci; 2017 Mar; 133(3):162-167. PubMed ID: 28302446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA receptor 2B subunit-mediated synaptic transmission in the superficial dorsal horn of peripheral nerve-injured neuropathic mice.
    Iwata H; Takasusuki T; Yamaguchi S; Hori Y
    Brain Res; 2007 Mar; 1135(1):92-101. PubMed ID: 17198690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of NMDA NR2B antagonist on neuropathic pain in two spinal cord injury models.
    Kim Y; Cho HY; Ahn YJ; Kim J; Yoon YW
    Pain; 2012 May; 153(5):1022-1029. PubMed ID: 22424878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methyl D-aspartate receptor subtype 2B antagonist, Ro 25-6981, attenuates neuropathic pain by inhibiting postsynaptic density 95 expression.
    Huang LE; Guo SH; Thitiseranee L; Yang Y; Zhou YF; Yao YX
    Sci Rep; 2018 May; 8(1):7848. PubMed ID: 29777135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.